External quality assessment of noninvasive fetal RHD genotyping.

Published in: Vox sanguinis (2020)

This external quality assessment workshop demonstrates that despite the different approaches taken to perform the clinical assays, fetal RHD genotyping is a reliable laboratory assay to guide targeted use of Rh prophylaxis in a clinical setting.

Keyphrases

high throughput
genome wide
dna methylation
cancer therapy
drug delivery
single cell
genetic diversity